I was talking to a friend last night at a function. Oncology is making the most strides it ever has.
The treatments are becoming more and more customizable to specific cancers and specific areas, so this is certainly good news.
Fast Track also allows piecemeal submissions and a quicker turn around once the NDA is submitted so it is all good.
Just the fact that the FDA acknowledges that this is a needed drug is very positive.
The treatments are becoming more and more customizable to specific cancers and specific areas, so this is certainly good news.
Fast Track also allows piecemeal submissions and a quicker turn around once the NDA is submitted so it is all good.
Just the fact that the FDA acknowledges that this is a needed drug is very positive.
Recent BMY News
- Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/17/2026 08:15:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:29:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:28:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:27:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:26:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:25:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:24:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/01/2026 08:32:53 PM
- Janux secures $35 million milestone payment from Bristol Myers Squibb • IH Market News • 04/01/2026 02:01:33 PM
- Bristol Myers Squibb broadens multiple myeloma care initiative after nearly a decade • IH Market News • 03/31/2026 02:31:56 PM
- Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in Multiple Myeloma as Program Marks Ten Years • Business Wire • 03/31/2026 10:59:00 AM
- Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) • Business Wire • 03/29/2026 03:45:00 PM
- Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy™ (xanomeline and trospium chloride) • Business Wire • 03/28/2026 11:00:00 AM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 03/27/2026 08:05:11 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 03/26/2026 08:44:49 PM
- Bristol Myers Squibb Reinforces Leadership in oHCM with New Camzyos (mavacamten) Data at American College of Cardiology Annual Scientific Session & Expo 2026 (ACC.26) • Business Wire • 03/23/2026 10:59:00 AM
- Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab) • Business Wire • 03/20/2026 08:42:00 PM
- Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026 • Business Wire • 03/19/2026 10:59:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:24:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:23:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:22:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:21:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:20:12 PM
